Zobrazeno 1 - 10
of 5 727
pro vyhledávání: '"DELFORGE, M."'
Autor:
Mateos MV; Hospital Universitario de Salamanca, Instituto de Investigación Biomédica de Salamanca (IBASL), Centro de Investigación del Cáncer (IBMCC-USAL,CSIC), Salamanca, Spain. mvmateos@usal.es., Weisel K; University Medical Center Hamburg-Eppendorf, Hamburg, Germany., De Stefano V; Catholic University, Fondazione Policlinico A. Gemelli, IRCCS, Rome, Italy., Goldschmidt H; University Hospital Heidelberg, Heidelberg, Germany., Delforge M; University of Leuven, Leuven, Belgium., Mohty M; Sorbonne University, Saint-Antoine Hospital, AP-HP INSERM UMRs 938, Paris, France., Dytfeld D; Poznan University of Medical Sciences, Poznań, Poland., Angelucci E; Hematology and Cellular Therapy, IRCCS Ospedale Policlinico San Martino, Genova, Italy., Vincent L; Centre Hospitalier Universitaire de Montpellier, Montpellier, France., Perrot A; Centre Hospitalier Universitaire de Toulouse, Service d'Hématologie, Toulouse, France., Benjamin R; School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., van de Donk NWCJ; Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, Netherlands., Ocio EM; Hospital Universitario Marqués de Valdecilla (IDIVAL) Universidad de Cantabria, Santander, Spain., Roccia T; Janssen Global Services, Raritan, NJ, USA., Schecter JM; Janssen Research & Development, Raritan, NJ, USA., Koskinen S; Janssen-Cilag, Espoo, Finland., Haddad I; Janssen-Cilag, Issy-les-Moulineaux, France., Strulev V; Janssen Pharmaceutica NV, Beerse, Belgium., Mitchell L; J&J, Allschwil, Switzerland., Buyze J; Janssen Pharmaceutica NV, Beerse, Belgium., Filho OC; Legend Biotech USA Inc, Somerset, NJ, USA., Einsele H; Universitätsklinikum Würzburg, Medizinische Klinik und Poliklinik II, Würzburg, Germany., Moreau P; University Hospital Hotel-Dieu, Nantes, France.
Publikováno v:
Leukemia [Leukemia] 2024 Dec; Vol. 38 (12), pp. 2554-2560. Date of Electronic Publication: 2024 Sep 25.
Autor:
Dimopoulos, M.A., Moreau, P., Terpos, E., Mateos, M.V., Zweegman, S., Cook, G., Delforge, M., Hájek, R., Schjesvold, F., Cavo, M., Goldschmidt, H., Facon, T., Einsele, H., Boccadoro, M., San-Miguel, J., Sonneveld, P., Mey, U.
Publikováno v:
In Annals of Oncology March 2021 32(3):309-322
Autor:
Doubinsky A; Department of Internal Medicine, Université Libre de Bruxelles, Brussels, Belgium., Miendje Deyi VY; Microbiology Unit, Laboratoire Hospitalier Universitaire de Bruxelles- Universitair Laboratorium Brussel, Brussels, Belgium., Mattheus W; Meningococcal National Reference Centre, Sciensano, Belgium., Delforge M; Department of Infectious Diseases, Saint-Pierre University Hospital, Brussels, Belgium., Libois A; Department of Infectious Diseases, Saint-Pierre University Hospital, Brussels, Belgium., Dauby N; Department of Infectious Diseases, Saint-Pierre University Hospital, Brussels, Belgium.; Center for Environmental Health and Occupational Health, School of Public Health, Université Libre de Bruxelles, Brussels, Belgium., Nasreddine R; Department of Infectious Diseases, Saint-Pierre University Hospital, Brussels, Belgium. rakan.nasreddine@stpierre-bru.be.
Publikováno v:
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology [Eur J Clin Microbiol Infect Dis] 2024 Dec 27. Date of Electronic Publication: 2024 Dec 27.
Autor:
Ailawadhi S; Division of Hematology/Oncology, Mayo Clinic, Jacksonville, FL., Arnulf B; Immuno-Hématologie, Hôpital Saint-Louis, l'Assistance publique-Hôpitaux de Paris, Université Paris Cite, Paris, France., Patel K; Department of Lymphoma-Myeloma, MD Anderson Cancer Center, The University of Texas, Houston, TX., Cavo M; Department of Medical and Surgical Sciences, Istituto di Ricovero e Cura a Carattere Scientifico, Azienda Ospedaliero-Universitaria di Bologna, Seràgnoli Institute of Hematology, Bologna University School of Medicine, Bologna, Italy., Nooka AK; Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA., Manier S; Medical and Oncology Specialties Department, Centre Hospitalier Universitaire de Lille, Université de Lille, Lille, France., Callander N; Department of Medicine, University of Wisconsin Carbone Cancer Center, Madison, WI., Costa LJ; Hematology & Oncology, The University of Alabama at Birmingham, Birmingham, AL., Vij R; Division of Oncology, Washington University School of Medicine in St. Louis, St. Louis, MO., Bahlis NJ; Department of Oncology, Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada., Moreau P; Hematology Department, University Hospital of Nantes, Nantes, France., Solomon S; Transplant and Cellular Immunotherapy Program, Northside Hospital Cancer Institute, Atlanta, GA., Abrahamsen IW; Department of Immunology, Oslo University Hospital, Oslo, Norway., Baz R; Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL., Broijl A; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Chen C; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada., Jagannath S; Multiple Myeloma Center of Excellence at Tisch Cancer Institute, Mount Sinai Medical Center, New York, NY., Raje N; Center for Multiple Myeloma, Massachusetts General Hospital, Boston, MA., Scheid C; Department of Medicine, University of Cologne, Cologne, Germany., Delforge M; Department of Hematology, Universitaire Ziekenhuizen Leuven, Leuven, Belgium., Benjamin R; Department of Heamatology, Kings College Hospital, London, United Kingdom., Pabst T; Department of Medical Oncology, Bern University Hospital, Bern, Switzerland., Iida S; Department of Hematology & Oncology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan., Berdeja J; Sarah Cannon Cancer Center and Tennessee Oncology, Nashville, TN., Giralt S; Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Truppel-Hartmann A; 2seventy bio, Cambridge, MA., Chen Y; Bristol Myers Squibb, Princeton, NJ., Zhong X; Bristol Myers Squibb, Princeton, NJ., Wu F; Bristol Myers Squibb, Princeton, NJ., Piasecki J; Bristol Myers Squibb, Princeton, NJ., Eliason L; Bristol Myers Squibb, Princeton, NJ., Dhanda D; Bristol Myers Squibb, Princeton, NJ., Felten J; Bristol Myers Squibb, Boudry, Switzerland., Caia A; Bristol Myers Squibb, Boudry, Switzerland., Cook M; Bristol Myers Squibb, Boudry, Switzerland., Popa McKiver M; Bristol Myers Squibb, Princeton, NJ., Rodríguez-Otero P; Department of Hematology, Clínica Universidad de Navarra, Pamplona, Spain.
Publikováno v:
Blood [Blood] 2024 Dec 05; Vol. 144 (23), pp. 2389-2401.
Autor:
Nanni C; Nuclear Medicine, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy., Deroose CM; Nuclear Medicine, University Hospitals (UZ) Leuven, 3000, Leuven, Belgium.; Nuclear Medicine and Molecular Imaging, Department of Imaging and Pathology, KU Leuven, Leuven, Belgium., Balogova S; Nuclear Medicine, Comenius University, Bratislava, Slovakia.; Médecine Nucléaire, Hôpital Tenon, GH AP.SU, Paris, France., Lapa C; Nuclear Medicine, Faculty of Medicine, University of Augsburg, Augsburg, Germany., Withofs N; Division of Nuclear Medicine and Oncological Imaging, Department of Medical Physics, CHU of Liege, Liege, Belgium.; GIGA-CRC in Vivo Imaging, University of Liege, Liege, Belgium., Subesinghe M; Department of Cancer Imaging, School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK., Jamet B; Médecine Nucléaire, CHU Nantes, F-44000, Nantes, France., Zamagni E; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli', Bologna, Italy. e.zamagni@unibo.it.; Dipartimento di Scienze Mediche e Chirurgiche, Università di Bologna, Bologna, Italy. e.zamagni@unibo.it., Ippolito D; Department of Diagnostic Radiology, Fondazione IRCCS San Gerardo dei Tintori, Via Pergolesi 33, 20900, Monza, Italy.; University of Milano-Bicocca, School of Medicine, Via Cadore 33, 20090, Monza, Italy., Delforge M; University Hospitals (UZ) Leuven, 3000, Leuven, Belgium., Kraeber-Bodéré F; Nantes Université, Univ Angers, INSERM, CNRS, CRCI2NA, F-44000, Nantes, France.
Publikováno v:
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2024 Dec; Vol. 52 (1), pp. 171-192. Date of Electronic Publication: 2024 Aug 29.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Coosemans, A., Vankerckhoven, A., Baert, T., Boon, L., Ruts, H., Riva, M., Blagden, S., Delforge, M., Concin, N., Mirza, M.R., Ledermann, J.A., du Bois, A., Vergote, I.
Publikováno v:
In European Journal of Cancer May 2019 113:41-44
Autor:
Hultcrantz M; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, NY. hultcram@mskcc.org., Kleinman D; Flaum Eye Institute, University of Rochester Medical Center, Rochester, NY., Vij R; Division of Medical Oncology, Washington University School of Medicine, St. Louis, MO., Escalante F; Hematology Department, University Hospital of Leon, Leon., Delforge M; Department of Hematology, Catholic University of Leuven, Leuven., Kotowsky N; Value, Evidence and Outcomes, GSK, Upper Providence, PA., Bitetti J; Global Medical Affairs, GSK, Zug., Boytsov N; Value, Evidence and Outcomes, GSK, Upper Providence, PA., Camadoo-O'Byrne L; Real World Study Delivery, GSK, Stevenage., Happ LP; Real World Data Strategy and Partnerships, Value, Evidence and Outcomes, GSK, Collegeville, PA., Germain G; Groupe d'Analyse, Ltee., Montreal, Quebec., Urosevic A; Groupe d'Analyse, Ltee., Montreal, Quebec., Mahendran M; Groupe d'Analyse, Ltee., Montreal, Quebec., Duh MS; Analysis Group, Inc., Boston, MA., Laliberte F; Groupe d'Analyse, Ltee., Montreal, Quebec., Cavo M; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seragnoli', Universita degli Studi di Bologna, Bologna., Lee HC; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.
Publikováno v:
Haematologica [Haematologica] 2024 Oct 17. Date of Electronic Publication: 2024 Oct 17.
Autor:
Nevejan L; Department of Laboratory Medicine, AZ Sint-Jan Brugge AV, Bruges, Belgium.; Department of Microbiology, Immunology and Transplantation, Clinical and Diagnostic Immunology, KU Leuven, Leuven, Belgium., Perkins M; Research and Development, Binding Site - Part of Thermo Fisher Scientific, Birmingham, United Kingdom., Vercammen M; Department of Laboratory Medicine, AZ Sint-Jan Brugge AV, Bruges, Belgium.; Observational Clinical Sciences, Vrije Universiteit Brussel, Brussels, Belgium., Vanhove T; Department of Laboratory Medicine, University Hospitals Leuven, Leuven, Belgium., Delforge M; Division of Haematology, University Hospitals Leuven, Leuven, Belgium.; Department of Oncology, Laboratory of Experimental Haematology, KU Leuven, Leuven, Belgium., Bossuyt X; Department of Microbiology, Immunology and Transplantation, Clinical and Diagnostic Immunology, KU Leuven, Leuven, Belgium.; Department of Laboratory Medicine, University Hospitals Leuven, Leuven, Belgium.
Publikováno v:
Clinical chemistry [Clin Chem] 2024 Oct 03; Vol. 70 (10), pp. 1291-1293.
Autor:
Nasreddine R; Saint-Pierre University Hospital, Brussels, Belgium., Yombi JC; Cliniques Universitaires Saint-Luc, Brussels, Belgium., Darcis G; Liège University Hospital, Liège, Belgium., Van Frankenhuijsen M; Institute of Tropical Medicine, Antwerp, Belgium., Van Petersen L; Institute of Tropical Medicine, Antwerp, Belgium., Abels C; MSD, Watermael-Boitsfort, Belgium., Dos Santos Mendes S; MSD, Watermael-Boitsfort, Belgium., Delforge M; Saint-Pierre University Hospital, Brussels, Belgium., De Wit S; Saint-Pierre University Hospital, Brussels, Belgium.
Publikováno v:
AIDS research and treatment [AIDS Res Treat] 2024 Sep 26; Vol. 2024, pp. 5590523. Date of Electronic Publication: 2024 Sep 26 (Print Publication: 2024).